Increasing Cases of Bone-Related Disorders are Going to Propel the Growth of the Topical Pain Relief Market

The global topical pain relief market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period (2022-2028). The rising prevalence of arthritis in many regions of the world has led to a surge in demand for topical pain relievers. Companies in the worldwide topical pain relief market will be able to generate income as a result of this factor. Additionally, the industry is expected to gain promising pathways as the number of people living with additional joint diseases rises. Different bone-related disorders are more common in the elderly population. As a result, the global expansion in this population is likely to benefit the growth of the topical pain relief market over the forecast period. In recent years, there has been a dramatic increase in public knowledge of non-opioid side effects. Furthermore, the number of persons suffering from chronic pain is rising. These factors are propelling the global topical pain relief market forward.  For instance, in 2021, AdvaCare offers Diclofenac cream is a nonsteroidal anti-inflammatory medication used to treat pain and other symptoms of arthritis of the joints (e.g. osteoarthritis), such as inflammation, swelling, stiffness, and joint pain. Diclofenac cream is a topical solution used to treat pain and swelling caused by osteoarthritis of the knees. For instance, in 2020 FDA approves GSK’s Advil Dual Action with Acetaminophen for over-the-counter use in the US. It is a combination of ibuprofen and acetaminophen for pain relief, the benefits of both active ingredients when safely treating their headaches, muscle aches, backaches, arthritis, and other joint pain.

Browse the full report description “Global Topical Pain Relief Market Size, Share & Trends Analysis Report by Formulation (Cream, Gel, Spray, and Others), and by Distribution Channel (Online and Offline) Forecast 2022-2028“at https://www.omrglobal.com/industry-reports/topical-pain-relief-gel-market-share 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Formulation
• By Distribution Channel 

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- including AdvaCare Pharma, Cipla Health Ltd., Exzell Pharma, GlaxoSmithKline Plc. Novartis AG, and Others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Topical pain Relief Market Report Segment

By Formulation

• Cream
• Gel
• Spray
• Others (Patch)

By Distribution Channel

• Online
• Offline  

Global Topical Pain Relief Market Report Segment by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa